SHR4640
Unknown / undisclosed
Evidence outlook · registrational
Gout: registrational trials complete
No completed mid-stage readout is on record. Its registrational studies have completed. Check News and the registry record for topline outcomes.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
Featured-trial selection for this indication is pending.
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 3 (2)
What this study did
What this study did
Phase 2 (4)
What this study did
What this study did
What this study did
What this study did
Phase 1 (14)
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
Competitive landscape
Other URAT1 (urate transporter 1, SLC22A12) drugs
Lingdolinurad. Compare all 2 URAT1 (urate transporter 1, SLC22A12) drugs
1 other tracked programme targets this mechanism, none of them ahead of this one.
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials | |
|---|---|---|---|---|---|---|
| SHR4640: this drug | Phase 3 | Undisclosed | URAT1 (urate transporter 1, SLC22A12) | not yet graded | No reviewed efficacy summary | |
| Lingdolinurad | Phase 2(overall) | Small molecule | URAT1 (urate transporter 1, SLC22A12) | not yet graded | No reviewed efficacy summary |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow SHR4640 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.